New York Life Investment Management LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1133639
New York, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,379,230
-$132,724 QoQ
Shares Held
24,104
-9.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#242
of 561 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $63,828,425 across 23 Biotechnology names. BMRN ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,218 | $21,467,677 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,588 | $10,343,281 | |
| 3 | MRNA |
Moderna, Inc.
|
91,235 | $6,389,187 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
23,449 | $4,391,528 | |
| 5 | TECH |
BIO-TECHNE Corp
|
41,589 | $2,938,262 | |
| 6 | INCY |
Incyte Corp
|
23,359 | $2,647,976 | |
| 7 | EXEL |
Exelixis, Inc.
|
29,245 | $1,591,220 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
24,104 | $1,379,230 |
All Filings in BMRN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,379,230 | 24,104 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,511,954 | 26,765 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,079,070 | 18,157 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,071,447 | 19,783 | Shares | Sole | 2025-11-06 | |
| 2024-09-30 | $334,439 | 4,758 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $366,368 | 4,450 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||